Steven C. Bishop

Array ( [id] => 8555410 [patent_doc_number] => 08329882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Genetic control of mammalian cells with synthetic RNA regulatory systems' [patent_app_type] => utility [patent_app_number] => 12/708506 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17312 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943518 [patent_doc_number] => 20110104138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/611746 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104138.pdf [firstpage_image] =>[orig_patent_app_number] => 12611746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6333976 [patent_doc_number] => 20100115641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/579032 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9113 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20100115641.pdf [firstpage_image] =>[orig_patent_app_number] => 12579032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6390829 [patent_doc_number] => 20100083391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Cancer Compositions, Animal Models, and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/568226 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8891 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20100083391.pdf [firstpage_image] =>[orig_patent_app_number] => 12568226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257485 [patent_doc_number] => 08206962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Hafnia phytase variants' [patent_app_type] => utility [patent_app_number] => 12/568312 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30034 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12568312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007071 [patent_doc_number] => 20110059102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Therapeutic Method Targeting Midkine' [patent_app_type] => utility [patent_app_number] => 12/554560 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8731 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059102.pdf [firstpage_image] =>[orig_patent_app_number] => 12554560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6484903 [patent_doc_number] => 20100092943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'SCREENING METHOD WITH THE USE OF TBK1 KNOCKOUT MOUSE' [patent_app_type] => utility [patent_app_number] => 12/507374 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7665 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092943.pdf [firstpage_image] =>[orig_patent_app_number] => 12507374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6507757 [patent_doc_number] => 20100216232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'MAMMAL DEDICATED CELL LINE' [patent_app_type] => utility [patent_app_number] => 12/506572 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216232.pdf [firstpage_image] =>[orig_patent_app_number] => 12506572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374142 [patent_doc_number] => 20090311703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHODS FOR IDENTIFYING FACTORS FOR DIFFERENTIATING DEFINITIVE ENDODERM' [patent_app_type] => utility [patent_app_number] => 12/476570 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 43080 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311703.pdf [firstpage_image] =>[orig_patent_app_number] => 12476570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379379 [patent_doc_number] => 20090191218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'DNA Vaccines And Methods For The Prevention Of Transplantation Rejection' [patent_app_type] => utility [patent_app_number] => 12/409351 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7615 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191218.pdf [firstpage_image] =>[orig_patent_app_number] => 12409351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6521427 [patent_doc_number] => 20100203195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Process for Separating High Purity Germ and Bran from Corn' [patent_app_type] => utility [patent_app_number] => 12/369287 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4415 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203195.pdf [firstpage_image] =>[orig_patent_app_number] => 12369287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125638 [patent_doc_number] => 20110086089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 12/866538 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32217 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086089.pdf [firstpage_image] =>[orig_patent_app_number] => 12866538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588822 [patent_doc_number] => 20100061997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Transgenic Non-Human Animals Expressing A Truncated Activin Type II Receptor' [patent_app_type] => utility [patent_app_number] => 12/361512 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 51770 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061997.pdf [firstpage_image] =>[orig_patent_app_number] => 12361512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467335 [patent_doc_number] => 20100190839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Telomere-Encoding Synthetic DNA Nanocircles, and Their Use for the Elongation of Telomere Repeats' [patent_app_type] => utility [patent_app_number] => 12/359448 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14757 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190839.pdf [firstpage_image] =>[orig_patent_app_number] => 12359448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355462 [patent_doc_number] => 20090186806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Truncated Activin Type II Receptor and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/360093 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 51770 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186806.pdf [firstpage_image] =>[orig_patent_app_number] => 12360093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778684 [patent_doc_number] => 20120041055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'COMPOSITE POLYNUCLEIC ACID THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/359949 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5820 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041055.pdf [firstpage_image] =>[orig_patent_app_number] => 12359949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627469 [patent_doc_number] => 20100172951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Enhanced Medical Implant' [patent_app_type] => utility [patent_app_number] => 12/348280 [patent_app_country] => US [patent_app_date] => 2009-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4155 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172951.pdf [firstpage_image] =>[orig_patent_app_number] => 12348280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527473 [patent_doc_number] => 20100212033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Novel ubiquitin lifases as therapeutic tragets' [patent_app_type] => utility [patent_app_number] => 12/317495 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 41254 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20100212033.pdf [firstpage_image] =>[orig_patent_app_number] => 12317495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146465 [patent_doc_number] => 08163470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Simulated 5-part differential leukocyte granules, the method for preparing the same and control products and calibrators comprising the same' [patent_app_type] => utility [patent_app_number] => 12/274070 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5706 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163470.pdf [firstpage_image] =>[orig_patent_app_number] => 12274070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629568 [patent_doc_number] => 08008460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Polynucleotide fragments of an infectious human endogenous retrovirus' [patent_app_type] => utility [patent_app_number] => 12/261374 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13556 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008460.pdf [firstpage_image] =>[orig_patent_app_number] => 12261374 [rel_patent_id] =>[rel_patent_doc_number] =>)